Use of medical resources and quality of life of patients with chronic heart failure: A prospective survey in a large Italian community hospital

European Journal of Heart Failure

Volumn 1, Issue 4, 1999, Pages 411-417

  Albanese, Maria C ^a   Plewka, Michal ^b,c   Gregori, Dario ^b   Fresco, Claudio ^a   Avon, Giorgio ^a   Caliandro, Donato ^a   Grassi, Libero ^a   Rossi, Paolo ^a   Udina, Paolo ^a   Bulfoni, Alessandro ^a   Colle, Roberto ^a   Cuzzato, Anna Linda ^a   Fioretti, Paolo M ^a,b  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b IRCAB Foundation   (Italy)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Health economics; Heart failure

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC ACID DERIVATIVE;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMMUNITY HOSPITAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITALIZATION; HUMAN; ITALY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SELF CARE; THORAX RADIOGRAPHY;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DATA COLLECTION; FEMALE; HEALTH RESOURCES; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HOSPITALS, COMMUNITY; HUMANS; ITALY; LENGTH OF STAY; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0033507947     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(99)00034-3     Document Type: Article

References (26)

1. Ho K.L., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 22(suppl A):1993;6A-13A.
2. Cowie M.R., Mostterd A., Wood D.A. et al. The epidemiology of heart failure. Eur Heart J. 18:1997;202-225.
3. Sinagra G.F., Perkan A., Zecchin M., Camerini F. L'epidemiologia dello scompenso cardiaco: un problema crescente di sanita publica. G Ital Cardiol. 25:1995;1043-1053.
4. Andersson B., Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J. 126:1993;632-640.
5. Shape N., Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet. 352(suppl I):1998;1-7.
6. Harjai K., Boulos L.M., Smart F.W. et al. Effects of caregiver speciality on cost and clinical outcomes following hospitalization for heart failure. Am J Cardiol. 82:1998;82-85.
7. Philbin E.F., DiSalvo T.G. Influence of race and gender on care process, resource use, and hospital based outcomes in congestive heart failure. Am J Cardiol. 82:1998;76-81.
8. Reis S.E., Holubkov R., Edmundowicz D. et al. Treatment of patients admitted to the hospital with congestive heart failure: speciality-related disparities in practice patterns and outcomes. J Am Coll Cardiol. 30:1997;733-738.
9. Edep M.E., Shah N.B., Tateo I.M., Massie B.M. Differences between primary care physicians and cardiologists in management of heart failure: Relation to practice guidelines. J Am Coll Cardiol. 30:1997;518-526.
10. Survey on heart failure in Italian hospital cardiology units. Results of the SEOSI study. Eur Heart J. 18:1997;1457-1464.
11. A new facility for the measurement of health-related quality of life. Health Policy. 16:1990;199-209.
12. Alzola C, Harrel F. An introduction to S-plus and Hmisc and Design libraries, 1997.
13. Rengo F., Acanfora D. Lo scompenso cardiaco nell'anziano. G Ital Cardiol. 24:1994;1423-1434.
14. Schweiger C., De Vita C., Langiano T. et al. Studio sulla epidemiologia e sull'assorbimento di risorse di ischemia, scompenso ed aritmie. G Ital Cardiol. 27(suppl 2):1997;3-54.
15. The task force of the Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J. 18:1997;736-753.
16. Effects of enalapril on mortality in severe congestive heart failure. Results of the north Scandinavian enalapril survival study. N Engl J Med. 316:1987;1429-1435.
17. Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
18. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 325:1991;293-302.
19. Cohn J., Archibald D., Ziesche S. et al. A comparison of enalapril with hydralasine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 325:1991;303-310.
20. Glick H., Cook J., Kinosian B., Pitt B.P. et al. Costs and effects of enalapril therapy in patients with symptomatic heart failure. An economic analysis of the SOLVD treatment trial. J Cardiac Failure. 1:1995;371-380.
21. Philbin E., Rocco T. Utility of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. Am Heart J. 134:1997;188-195.
22. Packer M. Do beta-blockers prolong survival in chronic heart failure? A review of the experimental and clinical evidence. Eur Heart J. 19(suppl B):1998;B40-B46.
23. Doughty R.N., Rodgers A., Sharpe N., MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Eur Heart J. 18:1997;560-565.
24. A randomized trial of beta-blockade in Heart Failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 90:1994;1765-1773.
25. Packer M., Bristow M.R., Cohn J.N. et al. US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
26. Guidelines for the diagnosis of heart failure. Eur Heart J. 16:1995;741-751.